MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today ...
InspireMD said the Food and Drug Administration approved its application to initiate a study of its SwitchGuard neuro protection system. Shares of the medical technology company rose 27%, to $1.15, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results